CAS: 419573-19-6 - N-[[(3S,6R)-5-amino-6-[(1R,4R,6R)-4,6-diamino-3-[(2S,4S,5S)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-3-hydroxy-tetrahydropyran-2-yl]methyl]-6-[5-[(4S)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pe
Fórmula:C34H62N8O12S
InChI:InChI=1/C34H62N8O12S/c35-15-10-16(36)31(54-33-28(48)25(38)27(47)21(13-43)52-33)29(49)30(15)53-32-17(37)11-19(44)20(51-32)12-40-24(46)7-2-1-5-9-39-23(45)8-4-3-6-22-26-18(14-55-22)41-34(50)42-26/h15-22,25-33,43-44,47-49H,1-14,35-38H2,(H,39,45)(H,40,46)(H2,41,42,50)/t15-,16-,17?,18?,19+,20?,21?,22+,25+,26?,27-,28?,29?,30-,31?,32-,33-/m1/s1
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Biotinamidocaproate tobramycin amide REF: 3D-AB18613CAS: 419573-19-6 | Min. 95% | A consultar | Ter 21 Jan 25 | |
Biotinamidocaproate Tobramycin Amide REF: TR-B389125CAS: 419573-19-6 | - - - | - - - | Produto descontinuado |
Biotinamidocaproate tobramycin amide
Ref: 3D-AB18613
1mg | A consultar | ||
2mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Biotinamidocaproate Tobramycin Amide
Ref: TR-B389125
5mg | Descontinuado | Solicitar informações | |
50mg | Descontinuado | Solicitar informações |